Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 3/20 | 0.89 |
| ▸ | MEN1 | O00255 | 7/20 | 0.85 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.85 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.85 |
| ▸ | RAB9A | P51151 | 5/20 | 0.85 |
| ▸ | HTT | P42858 | 4/20 | 0.85 |
| ▸ | LMNA | P02545 | 3/20 | 0.85 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.85 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.85 |
| ▸ | POLB | P06746 | 1/20 | 0.85 |
| ▸ | MMP2 | P08253 | 1/20 | 0.85 |
| ▸ | BLM | P54132 | 1/20 | 0.85 |
| ▸ | NPC1 | O15118 | 3/20 | 0.80 |
| ▸ | MITF | O75030 | 3/20 | 0.80 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.80 |
| ▸ | GPR174 | Q9BXC1 | 1/20 | 0.80 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.69 |
| ▸ | TP53 | P04637 | 1/20 | 0.66 |
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6568344 | 1.00 | KDM1A (0.89) | KDM1AMEN1KMT2AKDM4ERAB9A | |
| SCHEMBL683818 | 1.00 | KDM1A (0.89) | KDM1AMEN1KMT2AKDM4ERAB9A | |
| SCHEMBL14285643 | 0.94 | KDM1A (1.00) | KDM1AMEN1KMT2AKDM4ERAB9A | |
| SCHEMBL19283330 | 0.94 | KDM1A (1.00) | KDM1AMEN1KMT2AKDM4ERAB9A | |
| SCHEMBL684783 | 0.93 | KDM1A (0.82) | KDM1AMEN1KMT2AKDM4ERAB9A | |
| SCHEMBL684527 | 0.92 | KDM1A (0.81) | KDM1AMEN1KMT2AKDM4ERAB9A | |
| SCHEMBL684542 | 0.92 | KMT2A (1.00) | KDM1AMEN1KMT2AKDM4ERAB9A | |
| SCHEMBL14906893 | 0.92 | KDM1A (0.80) | KDM1AMEN1KMT2AKDM4ERAB9A | |
| SCHEMBL684844 | 0.92 | KDM1A (0.80) | KDM1AMEN1KMT2AKDM4ERAB9A | |
| SCHEMBL6751411 | 0.92 | KDM1A (0.85) | KDM1AMEN1KMT2AKDM4ERAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040110963-A1 | Novel hydrazones | ARPIDA AG (CH) | 2004-06-10 | — | — | US | disclosed |
| EP-1404644-A2 | NOVEL HYDRAZONES | Arpida AG, (CH) | 2004-04-07 | — | — | EP | disclosed |
| WO-2002070464-A2 | HYDRAZONES AND THEIR THERAPEUTIC USE | ARPIDA AG (CH) | 2002-09-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110963-A1 | Novel hydrazones | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HK1, MPO | KDM1A 2684/4885MEN1 2514/4885KMT2A 3368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.